Business · 28/04/2014Updated: 10/17/2026 · 1 min read
FDA Announces Proposed Collection of Information for Pharmacogenomic Data Submissions
Summary
The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to pharmacogenomic data submissions, which has been submitted to the Office of Management and Budget (OMB) for review and clearance under the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →